Alembic Pharma net profit up 21 percent at Rs 185 crore in Q2 Written By Ruchika Sharma5 Nov 2025 4:13 PM ISTNew Delhi: Alembic Pharmaceuticals Ltd has reported a 21 percent year-on-year rise in consolidated net profit to Rs 185 crore for the quarter ended...
USFDA issues 9 observations for Canada contract manufacturing facility: Jubilant Pharmova Written By Ruchika Sharma5 Nov 2025 2:45 PM ISTNoida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has concluded an audit of Jubilant...
Zydus Wellness net sales up by 31 percent in Q2 FY26 Written By Ruchika Sharma5 Nov 2025 2:15 PM ISTAhmedabad: Reporting its second quarter results for FY 26, Zydus Wellness Limited, has reported a growth of 31 percent in Net Sales which...
USFDA inspection: Granules India Virginia arm gets EIR Written By Ruchika Sharma5 Nov 2025 1:45 PM ISTHyderabad: Granules India has announced that the United States Food and Drug Administration (US FDA) has issued an Establishment Inspection...
Zydus gets EIR for SEZ II manufacturing facility in Ahmedabad Written By Ruchika Sharma5 Nov 2025 12:45 PM ISTAhmedabad: Zydus has announced that the company has received an Establishment Inspection Report (EIR) from the United States Food and Drugs...
Marksans Pharma UK arm gets marketing nod for Exemestane 25mg film-coated tablets Written By Ruchika Sharma5 Nov 2025 11:45 AM ISTMumbai: Marksans Pharma Limited's wholly owned subsidiary in UK, Relonchem Limited has received marketing authorization for its product...
USFDA Announces Major Push to Speed Biosimilar Development, Slash Biologic Drug Costs Written By Farhat Nasim4 Nov 2025 5:13 PM ISTNew Delhi: In a significant policy move to make advanced treatments more affordable, the U.S. Food and Drug Administration (FDA) has announced new...
Ziller Medical Denied Manufacturing Nod for Cervical Cerclage Pessary Over Inadequate Safety Data Written By Parthika Patel4 Nov 2025 4:49 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has refused to grant manufacturing...
CDSCO Panel Asks Shilpa Biologicals to Revise Phase III Protocol for Recombinant Human Serum Albumin Study Written By Susmita Roy4 Nov 2025 4:39 PM ISTNew Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has sought major revisions in...
Banned in Himachal, YL Pharma Under Rajasthan Scanner After Spurious Drug Detection Written By Parthika Patel4 Nov 2025 4:30 PM ISTJaipur: In a major revelation, it has emerged that YL Pharma, the pharmaceutical company whose medicines were recently declared spurious in Rajasthan,...
Zydus bags tentative USFDA nod for Crohn's disease drug Budesonide delayed release Written By Ruchika Sharma4 Nov 2025 3:50 PM ISTAhmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) for Budesonide...
Gland Pharma profit rises 12 percent to Rs 184 crore in Q2 Written By Ruchika Sharma4 Nov 2025 3:02 PM ISTGland Pharma Ltd has posted a 12 per cent year-on-year rise in profit after tax (PAT) at Rs 84 crore for the quarter ended September 2025, supported...
